| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f11ac5ada799060f8c2e97b1ee47b80d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5aed5b073b928cd37b98d26428d8b2c2 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-065
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-06 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5308
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6878
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 |
| filingDate |
2014-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2016-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_174f4f2537fa95d0aa605ea1292c3609
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77d072ab9e2f54f42c1da1a7374383ae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9955b385816ed9a4228dcd0e8a8637e3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db7cd7ec2997508b13e1184694198290 |
| publicationDate |
2016-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2556177-B1 |
| titleOfInvention |
Detection of gluten peptides in human fluids |
| abstract |
Detection of gluten peptides in human fluids. # The present invention shows a method for the detection and quantification in human fluids, preferably urine, of gluten peptides resistant to gastrointestinal digestion. The presence or absence of gluten peptides is controlled by immunological assays based on specific antibodies against them. This methodology is applicable in the medical-clinical sector, both in the verification of compliance with the gluten-free diet and in the precise diagnosis in gluten intolerances, including those cases where the symptoms of celiac disease persist despite the supposed total absence of intake of gluten It is also applicable in the process of research and diagnosis of drugs for CD to verify the efficacy of therapies related to the elimination or sequestration of immunotoxic peptides from gluten. |
| priorityDate |
2014-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |